Heartsciences Inc. (HSCSW) — 10-Q Filings
All 10-Q filings from Heartsciences Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
HeartSciences' Cash Boosted by $3.8M Offering Amidst Continued Losses
— Sep 11, 2025 Risk: high
HeartSciences Inc. (HSCSW) reported a net loss of $2,054,994 for the three months ended July 31, 2025, a slight increase from the $2,051,689 net loss in the pri -
HeartSciences Inc. Files Q3 10-Q
— Mar 13, 2025 Risk: medium
HeartSciences Inc. filed its 10-Q for the period ending January 31, 2025. The filing details financial performance and business activities, including informatio -
HeartSciences Inc. Files Q2 2025 10-Q
— Dec 16, 2024 Risk: medium
HeartSciences Inc. filed its 10-Q for the period ending October 31, 2024. The filing details financial activities including common stock warrants and additional -
Heart Test Labs Files Q1 10-Q, Details Preferred Stock & Warrants
— Sep 12, 2024 Risk: medium
Heart Test Laboratories, Inc. filed a 10-Q for the period ending July 31, 2024. The filing details financial activities including the issuance of Series C Conve -
Heart Test Laboratories, Inc. Files 10-Q for Period Ending January 31, 2024
— Mar 14, 2024 Risk: medium
Heart Test Laboratories, Inc. (HSCSW) filed a Quarterly Report (10-Q) with the SEC on March 14, 2024. Heart Test Laboratories, Inc. filed a 10-Q for the period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX